Hancock Whitney Corp Surface Oncology, Inc. Transaction History

Hancock Whitney Corp

  • $3.07 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$5.16 - $7.98 $84,876 - $131,263
-16,449 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$6.45 - $9.09 $106,096 - $149,521
16,449 New
16,449 $123,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email